Pharmaceutical Analysis of Linagliptin and Empagliflozin using LC-MS/MS | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


Pharmaceutical Analysis of Linagliptin and Empagliflozin using LC-MS/MS

Author(s): Maha F. Abdel-Ghany, Omar Abdel-Aziz, Miriam F. Ayad, Mariam M. Tadros

A new LC-MS/MS method was developed for determination of empagliflozin and linagliptin in pharmaceutical pure forms and dosage forms. Regression parameters, LOD, LOQ, accuracy and precision were investigated. Linearity was found to be acceptable over the concentration ranges of 25 - 800 ng mL-1 and 50 - 1600 ng mL-1 for linagliptin (LG) and empagliflozin (EG), respectively. Sb and Sa values of (4.43 * 10-3 - 2.04) and (2.46 * 10-3 - 2.27) were acceptable for LG and EG, respectively. Furthermore, LOD and LOQ were found to be (4.45 ng mL-1 -13.50 ng mL- 1) and (11.08 ng mL-1 - 33.57 ng mL-1) for LG and EG, respectively. The results of accuracy and precision calculations including the mean of the recovery and the standard deviation were (99.73 % ± 1.38) and (100.15 % ± 1.15) for LG and EG, respectively. The optimized method was proved to be accurate for the quality control of the investigated drugs either in bulk or in pharmaceutical formulation.


Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry